Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Lexicon Pharmaceuticals, Inc. (NQ: LXRX)
2.210 USD  +0.030 (+1.38%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Lexicon Pharmaceuticals, Inc.
 
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Lexicon (LXRX) to Present Results from Phase 1 Trial for LX2931 at American College of Rheumatology Annual Meeting
October 27, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4096631 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Presents Phase 1 Clinical Trial Results for LX2931 At American College of Rheumatology Annual Meeting
October 25, 2008
from GlobeNewswire News Releases
Lexicon Presents Phase 1 Clinical Trial Results for LX2931 At American College of Rheumatology Annual Meeting
October 25, 2008
from GlobeNewswire News Releases
Lexicon to Report Third Quarter 2008 Financial Results On October 30, 2008
October 16, 2008
Conference Call and Webcast to Follow Read More
from GlobeNewswire News Releases
Beacon Equity Issues Technical Trade Alerts on Market Movers: CHRS, SSCC, VITA, CHTR, LXRX, CDNS
October 16, 2008
from PR Newswire
Technical Trade Alerts on Market Movers: CHRS, SSCC, VITA, CHTR, LXRX, CDNS
October 16, 2008
from ACCESSWIRE
Lexicon to Present Clinical Data for LX2931, an Investigational New Drug for Rheumatoid Arthritis
October 14, 2008
from GlobeNewswire News Releases
Morgan Stanley Downgrades Lexicon Pharmaceuticals (LXRX) to Underweight
September 08, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3969679 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharmaceuticals (LXRX) Launches Preclinical Development of New Drug Candidate for Glaucoma
August 13, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3906966 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharmaceuticals Identifies New Drug Candidate for Glaucoma
August 13, 2008
from GlobeNewswire News Releases
Zacks Analyst Blog Highlights: LoopNet Inc., Coca-Cola FEMSA S.A. de C.V., Fomento Economico Mexicano SAB de C.V., Corrections Corporation of America and Lexicon Pharmaceuticals Inc.
August 01, 2008
from Business Wire News Releases
Lexicon Pharmaceuticals' Drug Candidate for Irritable Bowel Syndrome Completes Phase 1 Clinical Trial Showing Positive Results
July 29, 2008
Phase 2 Proof-of-Concept Clinical Trial in IBS Patients to be Initiated by Year End Read More
from GlobeNewswire News Releases
Lexicon Pharmaceuticals Reports 2008 Second Quarter Financial Results
July 29, 2008
from GlobeNewswire News Releases
Lexicon to Report Second Quarter 2008 Financial Results On July 29, 2008
July 17, 2008
Conference Call and Webcast to Follow Read More
from GlobeNewswire News Releases
Zacks Analyst Blog Highlights: Corel Corporation, Alexion Pharmaceuticals, Proctor & Gamble, Lexicon Pharmaceuticals Inc. and American Public Education, Inc.
July 09, 2008
from Business Wire News Releases
Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals
June 10, 2008
Collaboration to Apply Chemetics(R) Technology to Lexicon Targets Read More
from PR Newswire
Lexicon's Drug Candidate for Carcinoid Syndrome Receives Fast Track Status From the FDA
June 03, 2008
LX1032 Multi-Dose Trial to be Initiated in June Read More
from GlobeNewswire News Releases
Lexicon Pharmaceuticals (LXRX) Implements Reorganization, Cuts Jobs in Texas and New Jersey
May 28, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3691838 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharmaceuticals Implements Reorganization to Deploy Resources Toward Drug Development Pipeline
May 28, 2008
from GlobeNewswire News Releases
Lexicon Pharmaceuticals to Present At the Bank of America Health Care Conference
May 08, 2008
from GlobeNewswire News Releases
Lexicon Pharmaceuticals (LXRX) Reports Q1 EPS In-Line, Misses Revenue Estimate
April 29, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3587881 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharmaceuticals Reports 2008 First Quarter Financial Results
April 29, 2008
Conference Call and Webcast At 5:00 p.m. Eastern Time Read More
from GlobeNewswire News Releases
Lexicon Pharmaceuticals to Present At the Morgan Stanley Global Healthcare Unplugged Conference
April 24, 2008
from GlobeNewswire News Releases
Lexicon to Report First Quarter 2008 Financial Results On April 29, 2008
April 21, 2008
Conference Call and Webcast to Follow Read More
from GlobeNewswire News Releases
Lexicon's Drug Candidate for Rheumatoid Arthritis, LX2931, Shows Positive Results in Phase 1 Clinical Trial
April 17, 2008
Dose-Dependent Decrease in Circulating Lymphocytes Observed Read More
from GlobeNewswire News Releases
Lexicon Presents Clinical Data for LX6171, a Drug Candidate for Cognitive Disorders
April 15, 2008
Lexicon Identifies Transporter in Brain as the Target for LX6171 Read More
from GlobeNewswire News Releases
Lexicon Pharmaceuticals to Present At the Future Leaders in the Biotech Industry Conference
March 20, 2008
from GlobeNewswire News Releases
Lexicon Pharmaceuticals 2007 Annual Report to Stockholders Available Online
March 14, 2008
from GlobeNewswire News Releases
Piper Jaffray downgrades Lexicon Pharmaceuticals (LXRX) to Neutral
March 07, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3438525 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss of $0.09, Beats By 3c
March 06, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3437145 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here